Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,934 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis

NCT01093326

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Phoenix, Arizona, United States
  • Scottsdale, Arizona, United States
  • Palo Alto, California, United States
  • Sacramento, California, United States
View all 71 locations
View Trial Details
Completed

Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis

NCT01006265

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Clinical Investigative Site 3132 Scottsdale, Arizona, United States
  • Clinical Investigative Site 3100 Tucson, Arizona, United States
  • Clinical Investigative Site 3115 Sacramento, California, United States
  • Clinical Investigative Site 3117 Stanford, California, United States
View all 115 locations
View Trial Details
Completed

Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis

NCT02425644

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Investigator Site 8045 Carlsbad, California, United States
  • Investigator Site 8311 Pomona, California, United States
  • Investigator Site 8036 Denver, Colorado, United States
  • Investigator Site 8065 Ormond Beach, Florida, United States
View all 162 locations
View Trial Details

Related conditions